Literature DB >> 29016416

The New Age of Bullying and Violence in Health Care: Part 3: Managing the Bullying Boss and Leadership.

Ellen Fink-Samnick1.   

Abstract

PURPOSE/
OBJECTIVES: PRIMARY PRACTICE SETTING(S):: Applicable to all health care sections where case management is practiced. FINDINGS/
CONCLUSIONS: This article is the third of a 4-part series on the topic of bullying in the health care workplace. Part 3 addresses the dimensions of the bullying boss and leadership, posing major implications for patient safety plus the mental health of staff members. The complex constructs and dynamics broached by the bullying boss and department leadership are explored. These include the underlying forces at play such as power, gender, leadership styles, plus weaves in assessment models. Strategic and proactive management of bullying by leadership is vital to workforce retention and well-being. IMPLICATIONS FOR CASE MANAGEMENT PRACTICE: The increasing incidence and impact of bullying across all sectors have made it a major workforce performance management challenge. Health care settings are especially tense environments, often making it difficult for individuals to distinguish between bullying behavior and high expectations for staff. Bullying impacts both direct targets and bystanders who witness the assaultive behaviors, with ethical implications as well.Case management is poised to promote a safe health care workplace for patients and practitioners alike amid these intricate circumstances. Understanding types of bullying bosses and leadership styles is integral to a case manager's success in the workplace.

Entities:  

Mesh:

Year:  2017        PMID: 29016416     DOI: 10.1097/NCM.0000000000000249

Source DB:  PubMed          Journal:  Prof Case Manag        ISSN: 1932-8087


  1 in total

1.  Factors influencing the behavior of bystanders to workplace bullying in healthcare-A qualitative descriptive interview study.

Authors:  Sandra Jönsson; Tuija Muhonen
Journal:  Res Nurs Health       Date:  2022-04-15       Impact factor: 2.238

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.